Alzheimer's disease gene therapy - Enoded Therapeutics
Latest Information Update: 30 Apr 2024
At a glance
- Originator Encoded Therapeutics
- Class Antidementias; Gene therapies
- Mechanism of Action Tau protein expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease